Advisor Group Holdings, Inc. Pet Vivo Holdings, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.72 - $2.45 $4,300 - $6,125	-2,500 Reduced 96.15%	100 $0
Q1 2023 May 12, 2023	SELL	$2.2 - $3.4 $5,500 - $8,500	-2,500 Reduced 49.02%	2,600 $7,000
Q4 2022 Feb 10, 2023	BUY	$1.85 - $2.69 $4,625 - $6,725	2,500 Added 96.15%	5,100 $9,000
Q2 2022 Aug 10, 2022	BUY	$1.3 - $2.63 $130 - $263	100 Added 4.0%	2,600 $4,000
Q1 2022 May 04, 2022	BUY	$1.25 - $3.97 $3,125 - $9,925	2,500 New	2,500 $5,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $5.04M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.